ALZHEIMER DEMENTIA
Clinical trials for ALZHEIMER DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DEMENTIA trials appear
Sign up with your email to follow new studies for ALZHEIMER DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new antibody treatment slow Alzheimer's? a major study aims to find out
Disease control Not yet recruitingThis study tests whether monoclonal antibody drugs can slow the progression of Alzheimer's disease in 120 people with mild cognitive impairment or mild Alzheimer's. Researchers will use PET scans to measure brain changes and see who benefits most from continued treatment, even if…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Could a lower dose of Alzheimer's drug be just as effective?
Symptom relief Not yet recruitingThis study looks at whether a lower dose of the drug lecanemab can work as well as the standard dose for people with early-stage Alzheimer's disease. About 140 adults aged 50-85 with mild cognitive impairment or mild Alzheimer's will be followed for 18 months. Researchers will co…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC